Breast Cancer and Survivorship in the 21st Century

Less is more, More or less

Albany, NY | June 15, 2019

DATE/LOCATION

Saturday, June 15, 2019
Marriott Albany
189 Wolf Road
Albany, NY 12205
518-458-8444

Registration

Seating is limited, register now to reserve your seat!

Program Overview

The 5th Annual Breast Cancer Symposium, Disparities on a Cellular Level and Patient Level, is being organized in collaboration with New York Oncology Hematology (NYOH) and myMedEd, Inc. This accredited conference will offer 20.25 continuing education credits and will be held August 4-6, 2023, at the Hudson Hall in Hudson, NY.

Educational Goal

Advances in our understanding of breast cancer's genetic and physiologic pathways have led to the development of targeted systemic therapies, improved surgical procedures and radiation techniques, and improved disease-free and overall survival benefits. This conference aims to educate the global medical oncology community in a forum that will facilitate the utilization of optimal treatment strategies and foster communication that will benefit the individual patient and the community.

TARGET AUDIENCE

Medical, surgical, and radiation oncologists, primary care physicians, gynecologists, medical professionals and health care professionals interested in breast cancer are invited to attend.

LEARNING OBJECTIVES

After completing this activity, participants will be able to:

Review the recent developments in breast surgical approaches, including upfront and after neoadjuvant chemotherapy, including the decision-making approach to axillary interrogation.
Discuss the disparities encountered and identified in the breast cancer patient.
Explain the rationale for reconstruction options post neoadjuvant chemotherapy and radiation therapy.
Discuss updates in breast cancer imaging for earlier detection.
Explore the understanding of subsets of aggressive breast pathology and molecular profiling.
Identify therapeutic advances in early and advanced hormone receptor- positive, HER2 neu overexpressing, and triple-negative breast cancer.
Review the advances in radiation therapy and outcomes, including short- course radiation therapy and de-escalation, and who may not need radiation therapy in breast conservation.
Describe the management of HER2-positive early breast cancer in the older patient and
Understand the psychosocial, histologic and treatment disparities of the older breast cancer patient.
Understanding genetic mutations and approach to treatment.
Identify the new and emerging systemic treatment options for breast cancer brain metastases beyond surgery and radiotherapy.
Understanding the science and therapeutic options using molecular profiling for patients with breast cancer.
Explain the mechanism of action and rationale for immunotherapy.
Discussing the psychosocial health of the oncology health provider.
Updates on nutritional health for patients with early and advanced breast cancer.
Bone health and when and when not to intervene

Hudson Hall at the Historic Hudson Opera House

327 Warren Street
Hudson, NY 12534

HOTEL ACCOMMODATIONS

Overnight accommodations at the Marriott Albany are offered at a special rate of $129/night. Hotel rooms are blocked for the nights of June 4 and 5, 2020. The hotel will extend the negotiated rate to the nights before and after the conference based upon availability.

MAKE YOUR RESERVATION

- You may also call the hotel directly to make your reservation at 518-458-8444 and mention Group Code: Med Ed BCS.
- Reservations must be made by May 14, 2020, to receive the special rate.
- Complimentary parking is available.
- Event staff will be glad to assist you with any special needs (physical, dietary, etc.). Contact us

Planning Committee

Maria Theodoulou, MD (Course Chair & Moderator)
Program Director
Breast Cancer Medicine
New York Oncology Hematology
Albany, NY

FACULTY

The esteemed faculty of the Breast Cancer Symposium are excited to see you in 2024. Most of them have already accepted their invitations to present, while others are being added daily.

Francis Arena, MD
Director, NYU Langone Arena Oncology
Clinical Professor, NYU Health Medical College
President and Director of Research, Sass Foundation for Medical Research
Lake Success, NY

Jeanne Carter, PhD
Head of the Family Sexual
Medicine Program/Attending Psychologist
Memorial Sloan Kettering Cancer Center
New York, NY

Chau T. Dang, MD
Medical Director, MSK Westchester Medical Oncology
Attending, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
New York, NY

VK Gadi, MD, PhD
Professor and Director, Medical Oncology
Associate Director, Translational Medicine
University of Illinois Cancer Center
Chicago, IL

Heidi Godoy, DO
Gynecologic Oncologist
New York Oncology Hematology
Albany, NY

Yasmin Hasan, MD
Associate Professor
Department of Radiation and Cellular Biology
Residency Program Director
Director of Gynecological Brachytherapy
University of Chicago Medical Center
Chicago, IL

Claudine Isaacs, MD, FRCPC
Professor of Medicine and Oncology
Associate Director, Clinical Research
Leader, Clinical Breast Cancer Program
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

Neil Iyengar, MD
Associate Attending Physician
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
Associate Attending
Rockefeller University
New York, NY

Komal Jhaveri, MD, FACP
Associate Attending Physician
Section Head, Endocrine Therapy Research Program
Clinical Director, Early Drug Development Service
Memorial Sloan Kettering Cancer Center
New York, NY

Quincey LaPlant, MD, PhD
Assistant Attending Radiologist Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY

Terry P. Mamounas, MD, MPH, FACS
Medical Director, Comprehensive Breast Program
Orlando Health Cancer Institute
Professor of Surgery
University of Central Florida
Orlando, FL

Jennifer L. Marti, MD
Assistant Professor, Surgery Breast Surgical Oncology
Mount Sinai-Icahn School of Medicine
New York, NY

Beryl McCormick, MD, FACR
Attending Radiation Oncologist
Department of Radiation Oncology
Memorial Hospital
Professor of Radiology
Weill Cornell Medical School
New York, New York

Babak Mehrara, MD
Chief of Plastic and Reconstructive Surgery
Memorial Sloan Kettering Cancer Center
New York, NY

Elizabeth Morris, MD
Professor and Chair of Radiology
UC Davis Health
Sacramento, CA

Hyman B. Muss, MD
Mary Jones Hudson Distinguished Professor of Geriatric Oncology
Professor of Medicine, University of North Carolina
Director of Geriatric Oncology, Lineberger Comprehensive Cancer Center
Chapel Hill, NC

William Newman
Litigation Attorney & Partner
Oberheiden, P.C.
New York, NY

Anne O’Dea, MD
Associate Professor, Breast Medical Oncology
Director, Breast Cancer Survivorship
University of Kansas School of Medicine
Kansas City, KS

Joyce O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Chair, Breast Cancer Research Program
Baylor University Medical Center Chair, Breast Cancer Research Texas Oncology/US Oncology Network
Dallas, TX

Edith A. Perez, MD
Chief Medical Officer
Bolt Biotherapeutics, Inc.
Professor of Medicine
Mayo Clinic
Redwood, CA

Mark E. Robson, MD
Chief, Breast Medicine Service Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weil Cornell Medical College
New York, NY

George W. Sledge, Jr. MD
Executive Vice President
Chief Medical Officer
Caris Life Sciences
Palo Alto, CA

Tiffany A. Traina, MD
Vice Chair, Oncology Care
Section Head, Triple Negative Breast Cancer Clinical Research Program
Associate Attending Physician
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Associate Professor
Weill Cornell Medical College
New York, NY

Jessica A. Wilcox, MD
Assistant Attending Physician
Memorial Sloan Kettering Cancer Center

Maria Theodoulou, MD (Course Director)

Medical Oncologist

New York Oncology Hematology

Albany, NY

Francis Arena, MD
Director, NYU Langone Arena Oncology
Clinical Professor, NYU Health Medical College
Lake Success, NY

Jeanne Carter, PhD
Head, Female Sexual Medicine and Women's Health Program
Memorial Sloan Kettering Cancer Center
New York, NY

Todd Doyle, MD
Director of Radiation Therapy
New York Oncology Hematology
Albany, NY

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and myMedEd, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The Medical Society of the State of New York designates this live activity for a maximum of 20.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board. As an ACCME-accredited provider, MSSNY will identify and mitigate relevant financial relationships of all individuals who control CME content.

ASSURANCE OF BALANCED, UNBIASED, AND FAIR CONTENT

As an ACCME-accredited activity, relevant financial relationships of all individuals controlling CME content must be identified and mitigated. Financial relationships are relevant if the following three conditions are met for the prospective person who will control the content of the education:

■ A financial relationship, in any amount, exists between the person in control of content and an ineligible company.

■ The financial relationship existed during the past 24 months.

■ The educational content is related to the products of an ineligible company with whom the person has a financial relationship.

Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use.

This Activity Is Planned By myMedEd, Inc.